T
en years ago, China hatched an ambitious plan to bring home its best and brightest scientists and entrepreneurs. Government officials would offer funding, tax breaks, and other perks to Chinese-born luminaries working overseas — and appeal to their sense of nationalism — to convince them to permanently relocate to China to feed what they hoped would be a renaissance in the country’s long underachieving biotech sector.
That renaissance has materialized: China’s biotech sector is indeed rising as a powerhouse.
Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!
SUBSCRIBE TODAYWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
